average weight loss first month tirzepatide on Tirzepatide: Real Expectations average weight loss first month

The table below outlines what typically happens during daily use

"Melanocortin 1 Receptor (MC1R) Gene Variants are Associated with an Increased Risk for Cutaneous Melanoma Which is Largely Independent of Skin Type and Hair Color"

Clinical trials indicate that the average weight loss with semaglutide 2.4 mg weekly ranges from 12-15% of initial body weight over 68 weeks

Funding: This work was supported by National Natural Science Foundation of China (Grant No#: 81471026, to A.W.) and Diabetes Doctors Foundation of China (to A.W.)

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist, whereas semaglutide only targets the GLP-1 receptors